With the most recent additions to our partnership and board, Hoffmann & Partner has extended their offering to include executive CFO services for listed clients including clients pursuing a listing to an international stock exchange. Further the company now as well offers finance transformation advisory to get the company ready for digitalization and increased reporting requirements as well as capital market advisory services in the context of IPOs and/or public debt offering.
As a first mandate Hoffmann & Partner has won Kuros Biosciences which is specialized in orthobiological products in the context of spinal fusions and is listed on the Swiss Stock Exchange. Please see the press release announced on February 16, 2023 Kuros Biosciences Announces Changes to Executive Management Team – Kuros Biosciences.
We are convinced that through this extension of our offering, we can expand our service level and provide a complete finance ecosystem from start-up through to listing and beyond.